CMS Issues “Coverage With Evidence Development” Draft Guidance
This article was originally published in The Gray Sheet
Executive Summary
CMS' "coverage with evidence development" (CED) draft guidance appears to venture into FDA's traditional jurisdiction of evaluating safety and effectiveness
You may also be interested in...
Questions Linger Over Coverage-With-Evidence-Development Guidance
CMS' latest direction on coverage with evidence development has small manufacturers still guessing how far the agency intends to extend its oversight and how much of the burden of fulfilling CMS' goals will fall to firms
Questions Linger Over Coverage-With-Evidence-Development Guidance
CMS' latest direction on coverage with evidence development has small manufacturers still guessing how far the agency intends to extend its oversight and how much of the burden of fulfilling CMS' goals will fall to firms
AHRQ Works To Complete Patient Registry Reference Guide
HHS' Agency for Healthcare Research & Quality aims to complete a reference guide intended to facilitate wider use of patient registries by the end of the year